@Mason14 Thank you as always for explaining the science in layman's terms and your very valuable input.
I was wondering what Bisantrene's course of treatment could look like for metabolic disorders and other conditions, excluding cancer.
My current assumption is as follows: prior to giving Bisantrene to a cancer patient, readings of the patient's level of FTO would be required to diagnose FTO over-expression in the first place - and then to fine-tune the appropriate dosage before & in between administering. Is this correct?
Wouldn't similar diagnosis be required for metabolic disorders? Wouldn't this make Bisantrene impractical as a drug for metabolic diseases? I understand FTO deregulation (over-expression AND under-expression) can both cause health issues.
Finally another concern w.r.t metabolic disorders is business-related. For instance RAC would need to demonstrate value to a potential buyer with deep pockets to perform further clinical research. A few months ago, Dr T explained that trialing Bisantrene for obesity was very unlikely due to regulatory obstacles i.e. Bisantrene's safety profile must be absolutely bulletproof since obesity is not broadly a life-threatening condition. Which is why I would personally put $0 value on anything outside of the 3 pillars at this stage.
Thanks for your input,,
- Forums
- ASX - By Stock
- Pillar 1 - FTO (new thread)
@Mason14 Thank you as always for explaining the science in...
-
- There are more pages in this discussion • 2,063 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.55 |
Change
-0.020(1.27%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$1.59 | $1.62 | $1.51 | $218.3K | 138.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 95 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 157 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 95 | 1.525 |
3 | 29100 | 1.500 |
1 | 353 | 1.470 |
2 | 3444 | 1.440 |
3 | 101000 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.550 | 157 | 1 |
1.580 | 6715 | 2 |
1.600 | 2319 | 1 |
1.620 | 5327 | 1 |
1.630 | 1270 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |